Consumer Groups Push KFC to Stop Routine Antibiotic Use in Its Chicken

As per federal government guidance, KFC does not allow the use of such antibiotics for growth promotion. Medical experts warn that the routine use of antibiotics to promote growth and prevent illness in healthy farm animals contributes to the rise of drug-resistant “superbug” infections that kill at least 23,000 Americans each year and represent a “catastrophic threat” to global health.

Read More
Shareholders press Yum for stricter antibiotics policy

The proposal from shareholder activists As You Sow, of Oakland, California, and the Sisters of St. Francis of Philadelphia comes as KFC lags rivals McDonald’s Corp (MCD.N), Chick-fil-A, Subway and Wendy’s Co (WEN.O) in setting policies to curb the routine use of antibiotics in chicken production.

“Yum Brands’ silence in the face of this looming antibiotic resistance crisis is bad for business,” said Austin Wilson, As You Sow’s environmental health program manager.

Read More
Disney revenue rises 9 percent on success of ‘The Jungle Book’

● Yum Brands investors on Tuesday filed a shareholder proposal requesting that it quickly phase out harmful antibiotic use in its meat supply, taking aim at the practices of the company’s KFC fried chicken chain. The plan from shareholder activists As You Sow of Oakland, Calif., and the Sisters of St. Francis of Philadelphia comes as KFC lags rivals McDonald’s Corp., Chick-fil-A, Subway and Wendy’s Co. in setting policies to curb antibiotic use.

Read More
Success And Shareholders -- Why Companies Should Engage

Since 1992, As You Sow has used shareholder advocacy to increase corporate responsibility on a broad range of environmental and social issues. As shareholder advocates, we communicate directly with corporate executives to collaboratively develop and implement business models which reduce risk, benefit brand reputation, and increase the bottom line—while simultaneously bringing positive environmental and social change.

Read More
One-Third Southern Company shareholders vote for more renewable energy

Shareholder resolutions filed at Southern Company by an advocacy group, As You Sow, and faith-based investor coalition, the Tri-State Coalition for Responsible Investment (“Tri-State CRI”) sent Southern Company’s Board and management a strong message: to reduce carbon asset risk and align its business with a “2 degrees” climate scenario, according to a press release.

One resolution, by As You Sow, would have required Southern Company to quantify and disclose its “carbon asset risk,” or the potential losses to shareholders from coal operations.

Read More
Energy reserves proposal has Chevron over a barrel

“In a carbon-constrained world, what’s going to happen with these companies?” asked Danielle Fugere, president and chief counsel of the activist group As You Sow. “Traditionally, they’ve had to replace their reserves, or the market penalizes them. So how do they make this transition that we think is necessary?”

Chevron’s corporate board, however, has recommended shareholders reject the proposal, calling it unnecessary and confusing. As You Sow, based in Oakland, has presented the same proposal to ExxonMobil shareholders for their annual meeting on Wednesday, with Exxon’s board also opposing the change.

“It would be making a statement that Big Oil is really Big Energy,” said Andrew Behar, As You Sow’s chief executive officer. “When we have conversations with them, they keep saying, ‘No, no, we’re an energy company.’ And we say, ‘But you report in oil.’ You are what you measure.”

As You Sow’s proposal would expand that notion of comparing one resource to another, measuring all of an oil company’s reserves or energy-generating assets in BTUs. (One BTU represents the amount of heat required to increase the temperature of 1 pound of water by 1 degree Fahrenheit.)

Read More
A Millionaire Is Telling BlackRock to Say No to Big CEO Pay

Still, they vote with boards on executive pay 97 percent of the time, according to As You Sow, an advocacy group that has received financial support from Silberstein. That record conflicts with popular sentiment. About 74 percent of those surveyed in a nationwide poll in February don’t believe chief executive officers are paid appropriately relative to workers, and 62 percent say there should be caps on their pay. The survey, conducted by Stanford University’s Rock Center for Corporate Governance, found those views are held across the political spectrum, and despite respondents underestimating how much CEOs actually earn.

 

Read More
CEO PayAs You Sow
Danielle Fugere: Avoiding the fossil fuel cliff

As You Sow’s Carbon Asset Transition, or “CAT” resolution, requesting that oil companies’ energy resources be accounted for, by category, in resource-neutral energy units as well as barrels of oil, could have profound implications for the future. It allows oil and gas companies to decouple their asset base from a sole focus on fossil fuel reserves and incentivizes their transition into becoming energy companies ready to thrive in a low carbon economy.

Recognizing that an orderly transition to a clean energy future must be facilitated, As You Sow’s Carbon Asset Transition proposal is a crucial first step: by decoupling traditional oil and gas company value from a sole focus on carbon-based asset replacement, companies will have an opportunity and incentive to become truly diversified energy companies providing large-scale clean energy. In addition to directly engaging companies with this resolution and working with other energy companies on voluntarily reporting in BTUs, As You Sow will also file a petition with the SEC. The petition will request the SEC add an energy-neutral metric to its current reporting requirement for oil and gas companies. Such a change would help free these companies from their oilcentric focus, which made sense historically but whose time is now past.

Read More
Executive pay ‘rubber stamping’ rife

A report published in February by As You Sow, a US non-profit group, reinforced the view that investors do not want to take a tough stance on executive pay.

As You Sow highlighted BlackRock, the world’s largest asset manager, and Vanguard, the second largest, as two of the fund companies most likely to approve “excessive compensation for CEOs” routinely.

“The 100 most overpaid CEOs deserve more scrutiny than they are getting today from mutual funds and pension funds,” says Rosanna Landis Weaver, corporate pay expert at As You Sow.

Read More
CA Philanthropist Keeps BlackRock On Defensive With CEO Pay Shareholder Vote

A 2016 report from As You Sow, an organization that promotes environmental and social corporate responsibility through shareholder advocacy, identified BlackRock’s CEO, Laurence D. Fink, as the 51st most overpaid CEO in the S&P. Fink’s pay was raised 8 percent last year (to $25.8 million a year), nearly three times the 2.7 percent profit posted by the company — and at a time when BlackRock shares fell nearly 5 percent in value during the year.

That, As You Sow’s executive compensation analyst Rosanna Landis Weaver told Capital & Main, means that “BlackRock is a complete outlier in terms of votes. … Of the largest money managers, funds that have a lot of assets, Fidelity voted against [CEO pay packages] 21 percent; American Funds voted against 32 percent; Schwaab voted against 35 percent; and BlackRock voted against 3 percent from the ones that we looked at.”

Read More
Here’s Why We Can’t Rely on Shareholders to Fix CEO Pay

Shareholder advocacy group As You Sow has tracked mutual fund voting at the 100 firms whose CEOs the group has deemed “most overpaid,” based on various performance indicators. Although these firms all claim to care about carefully aligning the interests of CEOs and shareholders, As You Sow found 10 funds that rubber stamp pay packages at phenomenal rates. The giant Vanguard mutual-fund family, for example, gave bloated CEO pay packages the thumbs up 97 percent of the time last year. The firm has also come under fire for its North Korean Parliament–style voting on another set of inequality-related shareholder proposals, those that ask corporations to disclose their political spending.

The data from As You Sow raise a deeper question: In the end, can we really rely on shareholders to fix our broken CEO pay system?

Read More
CEO PayAs You Sow
Big Pharma Under Pressure to Pay For Drug Take-Back Programs

The pressure on pharma is not likely to die down. Recently, a non-profit “As You Sow” launched a campaign to push pharma companies to pay for take-back programs. The nonprofit sent a letter to the heads of ten pharmaceutical firms asking the companies to issue policy statements, notes STAT. It also placed shareholder resolutions calling on three drug makers to review their policies on take-back programs.

Read More
Profits are down at ExxonMobil, but don’t cry for CEO Rex Tillerson

“It’s outrageous. This is a man who has helped drive not only a company but maybe the world over a cliff,” said Rosanna Landis Weaver, an executive compensation specialist with As You Sow, a group that promotes social and environmental corporate responsibility and who believes Exxon should move into renewable energy. She said his compensation cut was “a largely symbolic reduction on a package that was exorbitant.”

Read More
Non-profit urges big pharma to take responsibility for drug take back programs

As You Sow recently sent a letter to the heads of ten pharmaceutical firms on behalf of the funds asking the companies to issue policy statements on drug take back programs. These programs are designed to reduce environmental contamination and lower the risk of prescription drug abuse from unused drugs.

The non-profit As You Sow is building on this local interest and hopes to force companies to address the disposal problem. In its letter, the group asks for companies to develop policies on the take back of unused drugs.

In addition, As You Sow has proposed shareholder resolutions requiring that Merck, Johnson & Johnson and AbbVie pay for the take-back programs. The reception from the three companies has been relatively cold, with all three drugmakers recommending shareholders vote against the proposals, according to Stat.

Read More